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Abstract
When it comes to clinical survival trials, regulatory restrictions usually require the application
of methods that solely utilize baseline covariates and the intention-to-treat principle. Thereby a
lot of potentially useful information is lost, as collection of time-to-event data often goes hand
in hand with collection of information on biomarkers and other internal time-dependent covari-
ates. However, there are tools to incorporate information from repeated measurements in a useful
manner that can help to shed more light on the underlying treatment mechanisms. We consider
dynamic path analysis, a model for mediation analysis in the presence of a time-to-event outcome
and time-dependent covariates to investigate direct and indirect effects in a study of different
lipid lowering treatments in patients with previous myocardial infarctions. Further, we address
the question whether survival in itself may produce associations between the treatment and the
mediator in dynamic path analysis and give an argument that, due to linearity of the assumed
additive hazard model, this is not the case. We further elaborate on our view that, when studying
mediation, we are actually dealing with underlying processes rather than single variables mea-
sured only once during the study period. This becomes apparent in results from various models
applied to the study of lipid lowering treatments as well as our additionally conducted simulation
study, where we clearly observe, that discarding information on repeated measurements can lead
to potentially erroneous conclusions.
1 Introduction
Survival and event history analysis has become a central interest in clinical biostatistics, as many clini-
cal trials are designed to investigate the effect of certain treatments on the time until the occurrence of
a particular event of interest, such as death or disease progression. As required by regulatory authori-
ties, typical approaches to assess these effects comprise of Kaplan-Meier plots along with log-rank tests
or of employing a Cox regression model including treatment and baseline covariates. Those analysing
strategies mainly focus on answering the rather pragmatic question ’Does treatment work?’.
Often collection of time-to-event data goes hand in hand with the collection of information on biomark-
ers and other internal time-dependent covariates, which are hardly ever used in the final analysis.
Thereby a lot of useful information is ignored, that could be used to address the more exploratory
question ’How does treatment work?’. A key tool to approaching answers to that question is media-
tion analysis, that allows for a decomposition of the total treatment effect into a direct effect and an
indirect effect. Emsley and co authors Emsley et al. (2010) give a historical overview of approaches
to mediation analysis and thereby discuss two - at first glance distinct appearing - traditions. On the
one hand, the estimation of direct and indirect effects by the method of path analysis together with
structural equation modeling Wright (1934); Duncan (1966); Goldberger (1972); Baron and Kenny
(1986) mainly motivated by social and behavioural sciences. On the other hand, the ’causal inference
approach’, mainly developed by statisticians and econometricians focusing on assumptions needed for
the identification of direct and indirect effects to draw valid inference Rubin (1974); Holland (1988);
Robins and Greenland (1992); Hafeman and VanderWeele (2011); Cole and Hernan (2002), also point-
ing out the problems that would occur when path-tracing rules and estimation techniques from linear
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models are transferred to non-linear models Kaufman et al. (2004); Pearl (2012).
Besides other obvious connections between these two traditions, one common issue was, that until the
last decade there was no straightforward approach on how to handle the estimation of direct and indi-
rect effects for survival outcomes. In 2006, Fosen and co-authors Fosen et al. (2006b,a) proposed the
model of dynamic path analysis, which we will mainly be concerned with in this paper, based on linear
regression and the additive hazard model Aalen (1980, 1989) . The approach was originally motivated
by recurrent event modeling and would - following the cartegorisation by Emsley and co-authors - fall
into the tradition of path analysis. Lange and Hansen Lange and Hansen (2011) developed a method
from a causal inference perspective and presented a way to obtain natural direct and indirect effects.
They make use of the additive hazard model as well, however, their approach is restricted to the setting
of a time-fixed, normally distributed mediator.
The model of dynamic path analysis enables us to exploit more information from data routinely col-
lected within clinical trials (or observational studies, as illustrated in Røysland et al. (2011); Gamborg et al.
(2011)) by utilizing repeated measurements of the mediator. The model is based on the idea that we
are actually dealing with continuous processes that evolve over time rather than fixed variables, as
pointed out in Aalen et al. (2014), and aims on modeling the effects of several covariate processes on
the occurrence of the event of interest and the relation between the covariate processes. It can be
viewed as an extension of classical path analysis Wright (1934) and the concept of directed acyclic
graphs (DAGs), an important tool in causal inference, to settings that involve time-to-event outcomes
and time-dependent covariates. The extensions are essentially, that a DAG is defined at each event
time and forms therefore a stochastic process in itself, that the path coefficients may change over time
and that the outcome is the occurrence of an event. However, making use of the additive hazard model
for the time-to-event outcome and linear regression for the treatment-mediator relationship, preserves
the rules for multiplying coefficients along paths, which would not be meaningful in non-linear models,
like for example the Cox model Kaufman et al. (2004); VanderWeele (2011).
Martinussen Martinussen (2010) derived the large sample properties of the dynamic path analysis
model and he further states that under the additional assumptions that the treatment-outcome rela-
tion and the mediator-outcome relation are un-confounded and there are no interactions between the
treatment and the mediator, the obtained estimates could be interpreted as truly causal effects. He,
however, emphasises the notion that no unique definitions of the concepts of direct, indirect and total
effects exist Pearl (2001); Robins and Greenland (1992); Goetgeluk and Vansteelandt (2009).
Further considerations within the field of causal inference motivated by the model have mainly ad-
dressed various scenarios where measured or unmeasured confounders could occur on the pathway
between the mediator and the outcome, which could themselves be affected by the exposure. For
example, Martinussen et al. (2011) propose a two-stage estimator for the controlled direct effect of
a point exposure on a survival outcome under one particular confounding situation. However, that
approach is limited to a time-fixed intermediate variable as well.
In this paper, we will assume that the treatment-outcome as well as the mediator-outcome relation-
ships are unconfounded and that no treatment-mediator interactions are present, and rather address
the question whether survival in itself may produce associations between the treatment and the me-
diator in dynamic path analysis. We give an argument showing that, due to linearity of the additive
hazard model, this is not the case, so selection by survival does not produce artificial association. This
implies the important property that, in case one finds the treatment mediator effect to be changing
over time, this is due to a real change of the effect and not caused by the survival selection mechanism.
A further important side-product of our argument is that covariates that affect survival in an additive
manner but are not considered as confounders will not turn into a confounders as time passes by.
For ease of presentation we present the underlying derivations for a single time point in the main
text. However, we provide an appendix that contains a generalisation of that argument, but involves
a mathematically more precise and therefore perhaps more complicated appearing notation.
To elaborate further on our view, that we are actually dealing with processes, we performed a simulation
study to compare the application of dynamic path analysis in the situation where the mediator is only
measured at one point in time compared to utilizing several measurement in a setting where we actually
assume the mediator to be a time-varying process. We can clearly observe that discarding information
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tends to obscure potential inference about the underlying mechanisms. Furthermore, we have data
available that were collected within the IDEAL study project (Incremental Decrease in End Points
Through Aggressive Lipid Lowering, Pedersen et al. (2005)), a multi-center clinical trial designed to
compare the effects of two different lipid lowering strategies on the risk of cardiovascular disease among
patients with established coronary heart disease (CHD). Enrolled patients were asked to repeatedly
return to the study center at pre-scheduled time points for monitoring their lipid values along with
other laboratory measurements. The trial was designed based on the mechanistic understanding that
statins would lower low density lipoprotein (LDL)-cholesterol levels, what would, in turn, result in a
reduced risk of coronary events. However, the trial did not show the expected results regarding the
primary outcome. Among other more in-depth considerations, the researchers also investigated the
proportion of the treatment effect mediated through different lipid measures Boekholdt et al. (2012),
but the applied methods were based on utilizing only a single measurement at a particular time point
Simes et al. (2002); Freedman et al. (1992). We employ dynamic path analysis to illustrate how the
direct and the indirect effects develop over time and also use a more broadly defined outcome, to utilize
more of the collected information.
The paper is structured as follows. First, we describe the concept of dynamic path analysis and the re-
spective estimation equations, followed by our argument concerning conditioning on survival in Section
3. In Section 4 we present results from our simulation study, followed by the results from applica-
tion to the IDEAL data in Section 5, and a discussion in Section 6. In an appendix we present the
generalisation of the argument explained in Section 3 to various time points and motivate the causal
interpretation of the described direct and indirect effects from Section 2.
2 Dynamic path analysis
As mentioned above the idea behind dynamic path analysis is to define a series of graphical models,
that depict the relationship between a time-fixed treatment (more baseline covariates could be added,
without destroying the big picture), a covariate process and the occurrence of the event of interest,
modelled as the infinitesimal change of a counting process. More specifically, we consider the situation
illustrated in Figure 1, where X1 would represent the statin treatment at randomisation in our appli-
cation, X2(t−) stands for the time-dependent mediator, e.g. LDL-cholesterol, and dN(t) essentially
refers to a jump in the counting process, which would then be a ’any CHD event’.
X2(t−)
β3,2(t)dt
$$■
■■
■■
■■
■■
X1
β(t)2,1
;;✇✇✇✇✇✇✇✇✇
β3,1(t)dt
11 dN(t)
Figure 1: Illustration of one time-local DAG.
To perform a dynamic path analysis one has to regress each node in the diagram onto its parents for
each event time. For the mediator-exposure relationship this can be done by ordinary linear regression,
whereas for the counting process increment we make use of the additive hazard model Aalen (1980,
1989).
Let us be more specific. Let N(t) = {N(t); t ∈ [0, τ ]} denote a right continuous counting process for
one particular individual. Given that we are considering survival data, N(t) will start at 0 and jump
to 1 if the individual experiences the event of interest. We want to model the ’jump-intensity’ within
a small time interval, given all information that has been observed prior to that interval, which we
heuristically denote as ’past’. Let dN(t) denote the increment of the counting process N(t) over a
small interval [t, t+ dt), then we can express the intensity process α(t) as
α(t)dt = P (dN(t) = 1| past),
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which we can alternatively express as E[dN(t)| past], since dN(t) is a binary variable. Applying well-
known results from counting process theory Andersen et al. (1993); Aalen et al. (2008), we have the
following decomposition
dN(t) = λ(t)dt+ dM(t),
where dM(t) is a martingale increment. Note that the decomposition is of the form ’observation =
signal + noise’ with dN(t) interpreted as the observation, λ(t)dt as the signal and dM(t) as the noise.
We further assume independent censoring (Aalen et al. (2008), Chapter 2) and introduce an ’at risk
indicator’ Y (t) at time t.
As stated above, for dynamic path analysis we want to make use of the additive hazard model to
describe the relationship between the change in the counting process and the covariate processes,
which takes following form
dN(t) = Y (t){β3,0(t) + β3,1(t)X1 + β3,2(t)X2(t−) + β3,3(t)Z1 + · · ·+ β3,p+2(t)Zp}dt+ dM(t). (1)
Here the first term on the right-hand side describes the intensity process as the product of the ’at
risk indicator’, Y (t), and a hazard function, α(t), corresponding to the term in curly brackets. Fur-
ther, the β3,j(t) are arbitrary regression functions, X1 denotes the time-fixed treatment, X2(t−) the
time dependent mediator and the vector Z relevant baseline covariates. For the treatment-mediator
relationship we assume a linear relationship
X2(t) = b2,0(t) + b2,1(t)X1 + b2,2(t)Z1 + · · ·+ b2,p+1(t)Zp +W2(t), (2)
where in this case b2,j(t) denote the respective regression coefficients at time t and W2(t) the error
term at time t. In applications, of course, different baseline covariates can be incorporated in (1) and
(2) depending on the setting, but we will use the index p throughout for the sake of simplicity. Further
we also assume
E[X2(t)|X1,Z, T > t] = b2,0(t) + b2,1(t)X1 + b2,2(t)Z1 + · · ·+ b2,p+1(t)Zp,
what will be further discussed in Section 3 and the appendix. For consistency with later sections, we
assume the following structure for X1
X1 = b1,0 +W1, (3)
with the error term W1 being independent of the error terms W2(t) at all times. Note that the case of
a binary treatment, as e.g. in our application section, is also covered in that formulation.
Use of the additive hazards model is a key ingredient in our approach. As described in section 2.1,
estimation in the additive hazards model focuses on the cumulative regression functions; see also section
4.2 in the book by Aalen et al. Aalen et al. (2008). For this reason we will (as in Røysland et al. (2011))
define the cumulative indirect and direct effects from our structural equation models in equations (1 -
3) as
dir(X1 → N(t)) :
∫ t
0
β3,1(s)ds (4)
and
indir(X1 → X2(t)→ N(t)) :
∫ t
0
b2,1(s)β3,2(s)ds. (5)
It should be noted, however, that our interest is in the local indirect and direct effects. So when
interpreting the cumulative effect estimates, we focus on their slopes. For more detailed elaborations
see Fosen et al. (2006b), where they also showed that the total cumulative effect can be obtained by
simply taking the sum over the cumulative direct and indirect effects.
In our appendix we motivate a causal interpretation of the time local direct and indirect effects,
integration then gives the respective cumulative effects. Heuristically speaking, the indirect effect
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reflects what would happen if we could manipulate the mediator X2(t) such that it behaved as if X1
had been perturbed, while we let X1 remain unperturbed. This idea resembles the definition of a
natural indirect effect, but without making explicit use of the counterfactual framework. The idea
underlying the direct effect is an intervention where X1 is perturbed, but the effect that perturbation
would have had on X2(t) can be attenuated. For a more general and mathematically more precise
description of these concepts it is referred to Sections B.2 to B.4 in the appendix.
2.1 Parameter Estimation
So far we have defined the cumulative direct and indirect effects in equations (4) and (5), now we briefly
want to recapitulate the estimation equations according to Røysland et al. (2011). Let us assume, we
have I independent observations of the above defined quantities, with individual values denoted as
Ni(t), Yi(t), X1i, X2i(t), Z1i, . . . , Zpi, Mi(t) for i = 1, . . . , I at time t . Let further L(t) be the matrix
with the i th row being equal to Yi(t)(1, X1i, X2i(t−), Z1i, . . . , Zpi) and N(t) and dM(t) the vector
consisting of the respective individual numbers of events Ni(t) and martingale increments dMi(t), as
well as dB(t) = (β3,0(t)dt, . . . , β3,p+2(t)dt)
T the vector of regression functions.
Then we can write (1) in matrix notation
dN(t) = L(t)dB(t) + dM(t),
which suggests that, given that L(t) has full rank, an estimator for the local effects dB(t), denoted as
dB̂(t), can be obtained by solving the estimation equations
L(t)T dN(t)− L(t)TL(t)dB̂(t) = 0
for every event time. The estimates dB̂(t) of the local effects may be quite variable. But we obtain
stable estimates of the cumulative regression functions B(t) by aggregating the local effects over all
event times up to and including time t.
For the mediator processes X2(t) we assumed a linear model
X2(t) = L˜(t)b2(t) +W2(t),
where the i-th line of L˜(t) equals Yi(t)(1, X1i, Z1i, . . . , Zpi) and W2(t) has zero-mean, is independent
of L(t) and its components are uncorrelated.
So the estimates bˆ2(t) can be deduced from the standard normal equations
L˜(t)TX2(t)− L˜(t)
T L˜(t)bˆ2(t) = 0
at each event time. Now we can insert the obtained local estimates dBˆ3,1(t) and dBˆ3,2(t) for β3,1(t)dt
and β3,2(t)dt and the respective OLS estimate for b2,1(t) in equations (4) and (5). Then the estimates
of the direct and indirect cumulative effects become sums over the observed event times. For more
details see Fosen et al. (2006b).
3 Survival collider issue
In the previos section we have discussed how dynamic path analysis can be viewed as a series of
local DAGs. However, when attempting to connect those DAGs as in Figure 2, one question became
apparent and that was whether survival in itself produces associations between covariates. In our case
that would imply that the association between the treatment and the mediator could partly be due to
survival selection, i.e. an artefact. Just to clarify, consider Figure 2, where X1 denotes the treatment,
X2(s0) the mediator value measured at baseline, say s0 and further dN(tj) the jump of the counting
process at time tj . One could speculate that when estimating the respective effects at event time t2 one
would potentially introduce spurious association between X1 and X2(s0) by conditioning on having
survived event time t1, which appears as a collider in the DAG.
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X2(s0)
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dN(t1) // dN(t2)
X1
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Figure 2: Simplest scenario where a survival collider effect could be suspected.
The following argument indicates, however, that this is not a problem, so in that case conditioning
on a collider (survival) does not produce artificial association.
We will first look at the case of two covariates that are independent at baseline and show that inde-
pendence is preserved under survival assuming the additive hazard model. In a second step, we will
consider covariates that satisfy a linear structural equation model and directly relate that case to the
simple dynamic path analysis model illustrated in Section 2.
3.1 Independence of covariates is preserved under survival in the additive
hazard model
Let X1 and X2 here denote two independent covariates measured at baseline. Under a simple additive
hazard model with no interactions, the probability of surviving up to time t is
C(t) exp
(
−(
∫ t
0
β1(s)ds)X1 − (
∫ t
0
β2(s)ds)X2
)
,
where C(t) results from taking the exponential of the integral over the baseline regression function.
Let T denote the survival time. Then
P (X1 = x1, X2 = x2|T > t)
=
P (X1 = x1, X2 = x2, T > t)
P (T > t)
=
P (T > t|X1 = x1, X2 = x2)fX1(x1)fX2(x2)
P (T > t)
where fX1(x1) and fX2(x2) are the densities of X1 and X2 at time 0. Inserting the survival probability
gives us
P (X1 = x1, X2 = x2|T > t)
=
C(t) exp
(
−(
∫ t
0
β1(s)ds)x1 − (
∫ t
0
β2(s)ds)x2
)
fX1(x1)fX2(x2)
P (T > t)
.
Hence the probability can still be factorized, so X1 and X2 are still independent at time t conditional
on survival.
The result can immediately be generalised to an additive model with K independent covariates and
no interactions.
3.2 Covariates satisfying a linear structural equation model
The above statement can be generalized to a very useful result about how the distribution of variables
in a linear structural equation model are changing under survival selection. Let us define an ordered
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linear structural equation model as follows (modification of Pearl (2009), equation (1.41), see also
Loh and Bu¨hlmann (2013))
Xk = bk,0 +
∑
j<k
bk,jXj +Wk.
This is defined for k = 1, . . . , n, and all Wk are assumed to be independent. Note that we assume this
model to be structural, hence there are no unmeasured confounders. In matrix form the model can be
written as follows with the solution in Wk on the right:
X = b0 +BX+W , X = (I−B)
−1
b0 + (I−B)
−1
W .
Here, B is a strictly lower triangular matrix. Assume that the hazard function is a linear combination
of the X ’s, then it is also a linear combination of the W ’s, and hence the independence of the W ’s are
preserved conditional on survival up to a given time t because of Section 3.1. Let Et denote conditional
expectation given survival up to time t, that is, T > t, then we have
Et[Xk − bk,0 −
∑
j<k
bk,jXj |Xj , j < k] = Et[Xk|Xj , j < k]− bk,0 −
∑
j<k
bk,lXj (6)
Since the independence of theW ’s are preserved under survival, the left hand side of the above equation
can be written in the following way:
Et[Xk − bk,0 −
∑
j<k
bk,jXj | Xj, j < k] = Et[Wk|Wj , j < k] = Et[Wk]
= Et[Xk − bk,0 −
∑
j<k
bk,jXj ] = Et[Xk]− bk,0 −
∑
j<k
bk,jEt[Xj ].
Comparing with (6), we have:
Et[Xk|Xj , j < k] =
∑
j<k
bk,jXj + Et[Xk]−
∑
j<k
bk,jEt[Xj ].
Hence, given survival at time t we have a linear model with the same coefficients that we had at time 0.
Hence there is a stable linear relationship between the variables under survival selection. The constant
term changes, but that does not matter.
3.3 Relation to a simple model for dynamic path analysis
Let us explicitly point out how the results above relate to dynamic path analysis. Assume that X1
is treatment and X2(s0) is the mediator, both measured at time zero. Assume that these covariates
constitute a simple structural equation model, that is
X1 = b1,0 +W1, X2(s0) = b2,0(s0) + b2,1(s0)X1 +W2(s0).
There are no unmeasured confounders either for the relationship between X1 and X2(s0) nor for their
influence on survival which is determined by the additive hazard model:
α(t) = β3,0(t) + β3,1(t)X1 + β3,2(t)X2(s0).
This is assumed to be a structural model. Given survival at any given time, say T > t, the relationship
between X1 and X2(s0) is still determined by the coefficient b2,1(s0). Hence, a simple calculation of
local direct and indirect effects of treatment X1 on hazard would be:
Direct effect: β3,1(t)
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Indirect effect: b2,1(s0)β3,2(t)
Note, that the same argument would locally apply, once we obtain an updated measurement of the
mediator, say X2(s1), and we would consider estimation of the effects around the path plotted as
dashed lines in Figure 3. It could occur that the estimate for the treatment-mediator relationship
b2,1(s1), differs from b2,1(s0). This difference, however, will be due to an actual change in the effect
that can be observed between the treatment and the updated measurement of the mediator but not
due to any selection bias. Referring once more to our real data application, that would for example
mean, that the effect of treatment on LDL-cholesterol levels indeed attenuates after some time.
X2(s0)
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Figure 3: Local path of interest for the estimation of direct and indirect effects, when an updated
measurement became available.
3.4 Collapsibility in the additive model
An important question is whether a factor that influences survival, but is un-related to other covariates,
can become a confounder over time. Let us assume there is an unmeasured quantity, that is not
considered a confounder at time 0 since it is only associated with survival and not with measured
covariates and there are no interactions present. It can be a part of the structural equation model
above, but with all the b’s equal to zero. It follows from the previous result that the b’s will stay
at zero conditioned on survival. Hence, unmeasured confounders do not arise due to survival collider
effects. If the Cox model is valid instead, this will not be true. In fact, any conceivable factor
influencing survival will become a confounder when time passes. The underlying reason for or the
different behavior of the two models arises from the collapsibility of the additive model (as discussed
in Martinussen and Vansteelandt (2013)), which does not hold true for the Cox model.
4 Simulation study
To further motivate investigations considering the mediator to be a time-varying process rather than
a time-fixed covariate, we performed a simulation study. We compared dynamic path analysis using a
single mediator measurement to dynamic path analysis using several measurements and also set those
results in relation to the true data generating model. In the subsequent section we describe our data
generating strategy for the survival outcome and mediator process and then show results from various
simulation scenarios. All simulations and analyses were performed in R, version 3.0.1 R Core Team
(2013)
4.1 Data generation
To generate data respecting the dynamic path analysis setting as presented in Section 2 with structural
equations as
X1 = b1,0 +W1
X2(s) = b2,0(s) + b2,1(s)X1 +W2(s)
α(s) = β3,0(s) + β3,1(s)X1 + β3,2(s)X2(s),
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we proceeded the following way:
Let us first consider the simulation of the time-to-event data. Generally, we assumed a study period of
5 years. This time period was discretised into equidistant grid points, where the distance, ∆, was set
to 1 week. For each interval of size ∆ the probability of an event within that interval can be expressed
as
P (th < T ≤ th +∆|T > th) = 1− exp
(
−
∫ th+∆
th
α(s)ds
)
.
Making use of the Taylor expansion this probability can be approximated by α(th)∆ and we can, in
turn, apply the additive form of the hazard α(th) including a time fixed or a time-dependent mediating
variable. Note beforehand, that the choice of values in the subsequent paragraph might seem rather
arbitrary at first glance, but the underlying idea was to create a situation that appears quite similar
to the real data example presented in the next section.
To model the flexible regression functions β3,j(s), we applied cubic splines and specified the function to
take the values (0.04, 0.03, 0.02, 0.02) at years (0, 1, 3, 5) for the effect of the mediating variable on the
hazard and to take the values (−0.3,−0.1,−0.6,−0.05,−0.05,−0.05) at years (0, 0.2, 0.8, 1.1, 3.5, 5) for
the effect of treatment. To model a 50 : 50 randomisation, the treatment variable was simply sampled
from a Bernoulli distribution. For the mediator process we first generated a baseline value, sampled
from a normal distribution with mean 11 and standard deviation 1.5. Again, we assumed a time-
varying effect of treatment on the mediator and modeled the time-dependent coefficient with a cubic
spline function (specified at times (0, 1, 2, 3, 4, 5) to take values (−0.1,−3,−2.2,−3.3,−2.9,−2.9)) and
added the time-varying treatment component to the sampled baseline values of the mediator and
additionally a noise term generated from a multivariate normal distribution with mean vector equal to
zero and a covariance matrix with diagonal elements set to 0.05 and non-diagonal number set to 0.0 .
After generating a treatment indicator, the mediator process and respective time-varying regression
functions β3,j(s) at each discrete time point th, we could insert the respective values into the function
for the hazard and calculate event probabilities for each individual at each discrete time point. This
enabled us to generate an event history for each individual by sampling from a Bernoulli distribution
with the calculated event probability at each time point. If an individual was sampled to have an event
at one particular time th its event indicator was set to one and the survival time to the discrete time
th where the event occurred. Censoring times were generated from a uniform distribution to account
in average for a 13% censoring rate. Individuals still alive and not censored at year 5 were censored
at that time point due to end of study.
4.2 Simulation scenarios
As stated above the main objective was to investigate what one could potentially gain from using
more than just one measurement of the mediator, assuming that the mediator is actually a time-
varying process. So a natural scenario to start with was, to just take one ’snap-shot’ measurement
from our generated mediator process and only utilize that measurement in the dynamic path analysis
model. Our flexible simulation procedure, however, allowed us to take ’snap-shot’ measurements at
various time points and to further make use of them in our model for analysis. For the ’snapshot’
measurements we simply picked values of the simulated mediator process at pre-specified time points
for every individual still in the study at those time points. Again the time points were chosen to mimic
the real data application.
4.3 Simulation results
In Figures 4 to 6 results based on 100 simulations based on trials of sample size 2000 are presented.
The scenarios vary in how many ’snap-shot’ measurements of the mediator were taken. In all plots the
true curve, displaying the assumed parameters for our simulations, is plotted as a dotted blue line, the
curve obtained from dynamic path analysis only using one mediator measurement is represented as a
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red dotted line, whereas the curve from dynamic path analysis using several mediator measurements
is displayed as a black solid line.
Figure 4: Simulation results, comparing a dynamic path model (DPA) only utilizing a single measure-
ment compared to a model using two measurement and the true model.
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Figure 5: Simulation results, comparing a dynamic path model (DPA) only utilizing a single measure-
ment compared to a model using three measurement and the true model.
Figure 6: Simulation results, comparing a dynamic path model (DPA) only utilizing a single measure-
ment compared to a model using four measurement and the true model.
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What can be observed throughout all considered scenarios is a tendency to underestimate the
indirect effect while overestimating the direct effect of treatment on the survival outcome when only a
single measurement is used. However, it also appears to be important at which particular time point
or state of the mediator process the measurements are taken. For example, comparing Figures 4 and
5 one can see that the model using 2 measurements gives actually better results for most of the study
period because the measurement of the mediator was taken at a time point where the treatment effect
on the mediator roughly equaled the average treatment effect of the remaining study period. A similar
pattern can be observed comparing Figures 4 and 6. For the study period after year 2, both direct
and indirect effects tend to deviate more from the truth in Figure 6. However, it can also be observed
that having more frequent measurements before year 2 makes it by far more likely to actually capture
the nature of the underlying process.
5 Analysis of the IDEAL data
In the following section we want to report the results from application of various dynamic path models
to the data collected within the IDEAL trial. Again, we primarily want to focus on comparing models
using a different amount of available mediator measurements.
5.1 The IDEAL study in brief
Recall, that we are dealing with a secondary prevention trial, that aimed to compare two different statin
treatment strategies (high dose of atorvastatin and standard dose of simvastatin) to lower cholesterol
levels in patients with previous myocardial infarction. Patients eligible to the study (for detailed
description of respective criteria see Pedersen et al. (2004)) were randomized to receive either 20 mg of
simvastatin or 80 mg of atorvastatin, with a foreseen possibility to change dose at week 24. Lipoprotein
levels (low density lipoprotein (LDL) - cholesterol, high density lipoprotein (HDL) - cholesterol, total
cholesterol (TC), triclycerides (TG), apolipoprotein B-100 (Apo B) , apolipoprotein A (Apo A)) from
fasting blood samples along with lever enzymes and other laboratory measurements were taken at
baseline, at 12 and 24 weeks, 1 year and yearly thereafter.
The primary endpoint was defined as time to first occurrence of a major coronary event (CHD).
However, to exploit more of the collected outcome information, we considered one of the broader
secondary endpoints, time to ’any’ coronary heart disease event, since - as mentioned above - our
main focus concerns the amount of mediator measurements used. (For more detailed definition of the
endpoints see Pedersen et al. (2005).)
5.2 Patient selection for the present analysis
From the originally 8888 randomised patients, after careful considerations, 8646 patients were left
for our analyses, as we required a certain amount of information to see any mediation effects in our
application of dynamic path analysis. More specifically, this means that we excluded patients that
had no baseline information on the considered mediator (described below) and also those still under
risk at week 12 but with missing mediator values, as those values are needed to actually observe an
effect of treatment. If successive measures of the time-dependent covariate were not on hand, the last
observation was carried forward.
5.3 Event frequency and deviations from the assigned treatment regime
From the previously mentioned 8646 patients, 4350 patients were originally randomised to 20 mg of
simvastatin and 4296 to 80 mg atorvastatin, where of 1019 patients experienced the event of interest in
the simvastin group and 852 in the atorvastatin group. However, the study design included the option
to adjust a patient’s dosage at week 24. As a result of these possible adjustments a fairly large number
of patients deviated from their allocated treatment at least once throughout the study period. In the
present paper, we decided to focus on the effects of allocating the described intervention in practice
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and therefore present our results from dynamic path analysis applying the intention-to-treat (ITT)
principle, analysing every individual as randomised.
Estimating effects comparing specific treatments at a specific dose would involve a more complicated
analysis due to the special study design and is therefore subject to further work on its own.
5.4 Potential Mediators
The a priori understanding of the underlying mechanisms made LDL-cholesterol the logical candidate
for a mediator. However, due to the ongoing debate in clinical literature, whether LDL-cholesterol
or apolipoprotein B (Apo B) should be considered as the target value for lipid therapy (see e.g.
Ramjee et al. (2011)), we also took Apo B into consideration as a potential mediator. Since Apo B
and LDL-cholesterol are highly correlated and it is still unclear in which way statin treatment effects
Apo B, we refrained from applying a more complex joint model and run separate analyses for LDL-
cholesterol and Apo B. To not to distract from the main points we indented to highlight, we only
present the development of the proportion of the effect mediated over time for LDL-cholesterol and
want to refer to supplementary plots of the actual path effects in the Apo B models.
5.5 Results
Throughout the IDEAL study blood lipids were measured at 7 measurement points after baseline. So
we decided to compare models where all available repeated measurements were utilized compared to
a reduced analysis were we only utilized the baseline and week 12 measurements of the mediator and
discarded all measurements after week 12. The reason for using the week 12 measurement was just
because one would not see any effect of treatment on the mediator and therefore any indirect effect
directly at administration of treatment.
In all models presented here the square root of LDL-cholesterol [mg/dL] was considered as the time-
dependent mediating variable X2(t). The models for the treatment mediator relationship as well as
the treatment outcome relationship included LDL-cholesterol at baseline (square root transformed),
APO B level [g/L] at baseline (square root transformed), high density lipoprotein [mg/dL] at baseline
(square root transformed) as well as smoking status, usage of statin treatments at randomisation,
and furhter presence of hypertension, presence of diabetes, sex and age at baseline, as those covariates
were reported to affect the risk of CHD events and also the LDL-cholesterol levels Mendis et al. (2011);
Jehle (2002) .
In the left-hand column of Figure 7 the estimated cumulative total, direct and indirect effects of
atorvastatin compared to simvastatin mediated through LDL-cholesterol are shown using all available
repeated measurements applying the ITT principle. In the right-hand column of Figure 7 one can find
the same arrangement of plots but for the analysis where only the baseline and week 12 measurements
of the mediator was used. The week 12 measurement was carried forward for that analysis, mimicking
a situation where one would only have access to one measurement.
In Figure 8 the corresponding linear regression coefficients and the cumulative direct effect of LDL on
the event outcome are displayed for these two models. Generally the patterns for the effect on LDL
as well as the results for the indirect effect fit the intuitive understanding quite well, that statins at a
higher dose have a rather rapid effect on LDL-cholesterol levels after receiving treatment, but it takes
some time until these effects actually effect the risk of cardiovascular disease.
Comparing the plots of the treatment effect on LDL-cholesterol in Figure 8 one can clearly see that the
effect of atorvastatin compared to simvastatin on the mediating variable actually attenuates over time.
By only utilizing the baseline and week 12 measurements, however, a constantly greater treatment
effect on the mediator is assumed. Comparing the plots for the indirect effects one can observe that
the indirect effect appears less pronounced when only the baseline and week 12 measurements are
incorporated in the analysis. This could be due to the general tendency to underestimate the indirect
effect that was also observable in the simulation study. Likewise, the direct effect of treatment behaves
similar to our simulation results, where could observe a tendency for overestimation. Attempting to
contribute to the ongoing discussion in clinical literature, we show the development of the proportion
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of effect mediated through LDL-cholesterol and Apo B in different plots in Figure 9. It can be observed
that the proportion of the effect mediated through Apo B has a more pronounced peak within the first
year and also stabilizes at a higher level thereafter.
6 Discussion
In this paper, we mainly addressed two issues around the model of dynamic path analysis. Most
importantly we could show, that conditioning on the collider ’survival’ does not produce artificial
associations between treatment and the mediator. This implies that whenever one finds the effect
between treatment and the mediator to be changing over time, that phenomenon corresponds to
an actual change in the relationship and is not spuriously introduced by survival selection. From our
given argument the important notion follows, that unmeasured quantities that are not considered to be
confounders but affect survival in an additive manner, will not turn into confounders as time passes by.
A property that will not hold true for the Cox model. This is a consequence of the fact that the additive
hazard model is collapsible, which is not the case for the Cox model Martinussen and Vansteelandt
(2013).
Other works around the dynamic path analysis model investigated specific confounding scenarios, but
only considered a time-fixed mediator Martinussen et al. (2011); Lange and Hansen (2011). In our
data example we, however, assumed no unmeasured confounding between exposure and outcome as
well as between the mediator and the outcome and aimed at a causal interpretation. But we are aware
that the estimated cumulative direct, indirect and total effects have to be interpreted with caution, as
these assumptions are generally not testable.
Concerning the results from our simulation study and our analyses of the IDEAL data we mainly want
to emphasis one issue that has, for example, been mentioned in Aalen et al. (2014). That is, when the
underlying mediating mechanism is actually working in time, performing mediation analyses that only
incorporate one single mediator measurement can distort the real picture and one may risk to deduce
false conclusions from such analyses.
Looking at our presented plots, a pattern that could be observed all over was, that the bootstrap
confidence intervals for the cumulative indirect effect appeared narrower than those for the direct effects
and consequently for the total effect. This phenomenon could also be observed in the applications
presented in Gamborg et al. (2011). We speculate that that could be due to measurement error in the
assessment of LDL-cholesterol and Apo B, which was reported to be a problem for multi-center studies
Contois et al. (2011).
Note that there are several other interesting challenges around the IDEAL data one could pick for
more in-depth analyses. For example, the issue of non-compliance with assigned treatment, which had
already been addressed in Holme et al. (2009). One possible extension would be to employ inverse
probability of censoring weights to and further perform reweighted dynamic path analysis model, as
suggested in Røysland et al. (2011).
From a practical perspective estimates of effects over time could improve study planning of future trails
with similar objectives. For example by considering the mediator as a surrogate endpoint, the respective
plots of the cumulative indirect effect could help to preplan the timing of interim measurements.
In summary, dynamic path analysis is a useful tool for mediation analysis with a time-dependent
mediator and a survival outcome. The obtained cumulative effect plots enable us to describe how
direct and indirect effects evolve over time, which can add to the mechanistic understanding of the
underlying processes. The linearity of the models for the treatment-mediator relationship as well as
for the hazard appears to have appealing properties.
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Figure 7: First column: Estimated cumulative total, direct and indirect effect of atorvastatin compared
to simvastatin mediated through LDL cholesterol using all available measurements; Second column:
Effect estimates only utilizing the week 12 measurement; Grey lines represent the 95% confidence
intervals based on 200 bootstrap samples.
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Figure 8: First column: Regression coefficients over time for the effect of atorvastatin compared to
simvastatin on LDL cholesterol and cumulative direct effect of LDL cholesterol on CHD using all
available measurements; Second column: Effect estimates only utilizing the week 12 measurement;
Grey lines represent the 95% confidence intervals based on 200 bootstrap samples.
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Figure 9: Proportion of treatment effect mediated through LDL-cholesterol vs. Apo B.
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APPENDIX: Causal interpretation in dynamic path analysis
A The statistical model
We will consider scenarios that fit the following combined longitudinal and time-to-event model:
A.1 Covariates
The main event of interest occurs at time T > 0, represented by a counting process Nt. In addition,
there are variables X1, . . . , Xn that can have outcomes before this event occurs. More precisely, we
assume that the outcome of each variable Xi occurs at a deterministic time ti if the main event has
not already occurred, i.e. if T > ti. We also assume that i < j means that the outcome of Xj can
not occur strictly before Xi. This means that we have deterministic times t1 ≤ · · · ≤ tn, possibly with
repetitions.
Let P denote the joint density that governs the pre-intervention frequencies of these variables, and
let b1, . . . , bn be functions on the form
bk(X1, . . . , Xk−1) = bk,0 + bk,1X1 + · · ·+ bk,k−1Xk−1. (7)
Assume that
Xk − bk(X1, . . . , Xk−1) ⊥⊥ {X1, . . . , Xk−1} | T ≥ tk, (8)
and
E[Xk|X1, . . . , Xk−1, T ≥ tk] = bk(X1, . . . , Xk−1), (9)
for every k > 1 and let
b1,0 = E[X1]. (10)
A.2 Covariate processes and additive hazards
The collection of possible events that could have occurred before t, the so-called history or filtration
generated by Nt and {Xi| ti ≤ t} will be denoted Ft. We will also need to consider the history
restricted to Nt and {Xi| ti ≤ t, i ≤ j}, which we will refer to as F
j
t . For mathematical convenience in
the subsequent derivations, let us also introduce the following caglad function, s 7→ Js from [0,∞) into
the n × n-matrices such that the only non-zero entries of Js are contained in the upper-left ns × ns-
corner, where ns := max {k|tk ≤ s}. This gives us a vector-valued ’covariate process’ s 7→ JsX that is
adapted to the filtration Fs.
Finally, we assume that there exist functions β0s and βs := (β
1
s , . . . , β
n
s )
⊺ such that
αs = β
0
s + β
⊺
s JsX (11)
defines the hazard of Ns with respect to the pre-intervention joint density P and the filtration Fs.
Let us illustrate these concepts with the following example. Suppose we have a situation with a baseline
variable and a ’process’ that takes the first value at baseline, while it takes a new value at a later time,
say t. Further, suppose the hazard of T , at time s, only depends linearly on the baseline variable and
the current value of the process. Now, let X1 denote the variable, X2 denote the baseline value of the
process and X3 the subsequent value of the process. This gives
Js :=
(
1 0 0
0 I(s ≤ t) I(s > t)
)
,
so for the covariate process we have (
X1(s)
X2(s)
)
= Js
X1X2
X3
 ,
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so that the hazard can be written as
αs = β
0
s + β
⊺
s Js
X1X2
X3
 .
A.3 Constant regression coefficients
Due to linearity, we can estimate the coefficients {bk,j}j>0 by performing ordinary linear regressions
among the survivors at any time after tk, i.e.
Proposition 1. If we restrict to outcomes such that T > t ≥ tk, then we have
E
[
Xk
∣∣Fk−1t ] = k−1∑
j=1
bk,jXj + E
[
Wk
∣∣T > t], (12)
where Wk := Xk − bk(X1, . . . , Xk−1).
B Causal inference
B.1 Causal validity
We will say that the model is causal if, for every V = (V1, . . . , Vn), we can specify interventions that
would have given joint densities P˜ such that (9) and (8) hold when each function bk is replaced by
bk+Vk, while α still defines a hazard with respect to P˜ . If the model is causal, we are able to calculate
the causal effects from these interventions on the marginal hazard of N .
Theorem 1. Let α0t and α˜
0
t denote the marginal hazards of Nt for P and P˜ respectively. We have
that
α˜0t = α
0
t +
∑
i
(
β
⊺
t Jt
)
i
Vi +
∑
l>i
(
β
⊺
t Jt
)
l
∑
p
bik,ik−1bik−1,ik−2 . . . bi2,i1Vi, (13)
where we sum over partitions p = (i1 = i < i2 < · · · < ik−1 < ik = l), which correspond to the paths
defined in Fosen, Section 2.5 Fosen et al. (2006b).
B.2 Mediation
Suppose we could perform an intervention that would only perturb the component Xi, i.e. we obtain
a joint density P˜ , where only the function bi is replaced by bi + ε.
We see from (13) that the effect seems to propagate through the system. To isolate the effect that
is mediated through a variable Xj , where j > i, we could instead manipulate the system such that Xj
behaved as if Xi had been perturbed, while we let Xi remain unperturbed.
Note that we have
bj(X1, . . . , Xi−1, Xi + ǫ,Xi+1, . . . , Xj−1) = bj(X1, . . . , Xj−1) + bj,i · ε.
This means that if the model is causal, then we could intervene such that bj(X1, . . . , Xj−1) is replaced
by bj(X1, . . . , Xj−1) + bj,i · ε to obtain a scenario as we just described. Therefore, by Theorem 1, the
mediated effect on the marginal hazard of N is given by∑
l>i
(
βtJt
)
l
∑
p
bik,ik−1bik−1,ik−2 . . . bi2,i1bj,iε, (14)
where we sum over partitions p such that p = (i1 = j < i2 < · · · < ik−1 < ik = l). This resembles the
classical definition of natural indirect effects that builds on nested counterfactuals, see Pearl (2009),
Robins and Greenland (1992) and Lange and Hansen (2011) Note that we are able to define indirect
effects without explicit use of nested counterfactuals by exploiting the linearity. It is an interesting
observation that this, at least approximately, gives meaning for non-linear models where b1, . . . , bn are
replaced by smooth-functions, since smooth functions behave as if they are affine for small ε.
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B.3 Causal pathways and path-effects
Suppose we are given a pathway:
Xi1 → Xi2 → · · · → Xik → Nt, (15)
where ij < ij+1. If the model is causal with respect to all the nodes Xi1 , . . . , Xik , then we can isolate
the effect that flows only through this path by first isolating the effect that is mediated by Xi2 , and
then iterate this contrast for each ij such that 1 < j ≤ k. This gives the following path-effect:(
βtJt
)
ik
bik,ik−1bik−1,ik−2 . . . bi2,i1ε. (16)
By Proposition 1, the path-effect along (15), as defined in the dynamic path analysis (Fosen et al.
(2006b)), is simply the integral of (16) in the special case ε = 1.
B.4 Direct effects
To isolate the effect from Xi that is not mediated through the other covariates, we have to attenuate
any other effect the intervention Xi 7→ Xi + ǫ would have had. For i 6= j, we want to change each
function bj such that Xj would behave as if Xi was not perturbed, even if it was. Note that
bj(X1, . . . , Xi−1, Xi − ǫ,Xi+1, . . . , Xj−1) = bj(X1, . . . , Xj−1)− bj,iε. (17)
This means that if we perturbed each function bj into bj − bj,iε while we also perturbed Xi such that
bi is replaced by bi + ε, then α˜t − αt represents the direct effect. The sum (13) telescopes for
V = (0, . . . , 0, ε,−bi+1,iε, . . . ,−bn,iε),
so the direct effect equals
α˜t − αt =
(
β
⊺
t Jt
)
i
ε. (18)
Note that the direct effect, as defined in the dynamic path analysis (Fosen et al. (2006b)), is simply
the integral of (18) in the special case ε = 1.
Proofs
Proof of Theorem 1. Let∇i denote the n×n-dimensional matrix where the i’th row equals
(
bi,1 . . . bi,i−1 0 . . . 0,
)
and all the remaining entries are 0. Moreover, let
φs(x1, . . . , xn) := β
⊺
s Js(I +∇n) . . . (I +∇2)
x1...
xn
 , (19)
and note that
φt(x1, . . . , xn) = φt(x1I(t ≥ t1), . . . , xnI(t ≥ tn)).
Lemma 1. Each Wj is independent of W1, . . . ,Wj−1 conditionally on T > t ≥ tj and
φt(W1, . . . ,Wj , E[Wj+1|T > t], . . . , E[Wn|T > t]) (20)
defines the hazard of T with respect to F jt with respect to both P and P˜ .
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Proof. For every continuous function h
E[h(Wn)|F
n−1
t ∩ {T > t}]
=
E[h(Wn) exp(−
∫ t
tn
φs(W1, . . . ,Wn)ds)|F
n−1
tn
∩ {T > tn}]
E[exp(−
∫ t
tn
φs(W1, . . . ,Wn)ds)|F
n−1
tn
∩ {T > tn}]
=
E[h(Wn) exp(−
∫ t
tn
φs(W1, . . . ,Wn−1, 0) + φs(0, . . . , 0,Wn)ds)|F
n−1
tn
∩ {T > tn}]
E[exp(−
∫ t
tn
φs(W1, . . . ,Wn−1, 0) + φs(0, . . . , 0,Wn)ds)|F
n−1
tn
∩ {T > tn}]
=
E[h(Wn) exp(−
∫ t
tn
φs(0, . . . , 0,Wn)ds)|F
n−1
tn
∩ {T > tn}]
E[− exp(
∫ t
tn
φs(0, . . . , 0,Wn)ds)|F
n−1
tn
∩ {T > tn}]
=
E[h(Wn) exp(−
∫ t
tn
φs(0, . . . , 0,Wn)ds)|T > tn]
E[exp(−
∫ t
tn
φs(0, . . . , 0,Wn)ds)|T > tn]
=E[h(Wn)|T > t].
Suppose that the independence claim is true for n, n − 1, . . . , j + 1. The innovation theorem implies
that (20) gives the hazard with respect to F jt .
Furthermore, we have that
E[h(Wj)|F
j−1
t ∩ {T > t}]
=
E[h(Wj) exp(−
∫ t
tj
φs(W1, . . . ,Wj , E[Wj+1|T > s], . . . , E[Wn|T > s])ds)|F
j−1
tj
∩ {T > tj}]
E[exp(−
∫ t
tn
φs(W1, . . . ,Wj , E[Wj+1|T > s], . . . , E[Wn|T > s])ds)|F
j−1
tj
∩ {T > tj}]
=
E[h(Wj) exp(−
∫ t
tj
φs(0, . . . , 0,Wj , 0, . . . , 0)ds)|F
j−1
tj
∩ {T > tj}]
E[exp(−
∫ t
tj
φs(0, . . . , 0,Wj , 0, . . . , 0)ds)|F
j−1
tj
∩ {T > tj}]
=
E[h(Wj) exp(−
∫ t
tj
φs(0, . . . , 0,Wj , 0, . . . , 0)ds)|T > tj ]
E[exp(−
∫ t
tj
φs(0, . . . , 0,Wj , 0, . . . , 0)ds)|T > tj ]
=E[h(Wj)|T > t]
So the independence claim is also true for j. The result therefore follows by induction.
Lemma 2.
EP˜ [h(Wi)|T > t] = EP [h(Wi + Vi)|T > t] (21)
for every i such that t > ti.
Note that for convenience of notation in the following proof we introduce the following notation
Wk(s) := EP [Wk|T > s] and W˜k(s) := EP˜ [Wk|T > s]
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Proof. We have that
EP˜ [h(Wn)|T > t]
=EP˜ [h(Wn)|F
n−1
t− ∩ {T > t}]
=
EP˜ [h(Wn) exp
(
−
∫ t
tn
φs(W1, . . . ,Wn)ds
)
|Fn−1tn ∩ {T > tn}]
EP˜ [exp
(
−
∫ t
tn
φs(W1, . . . ,Wn)ds
)
|Fn−1tn ∩ {T > tn}]
=
EP [h(Wn + Vn) exp
(
−
∫ t
tn
φs(W1, . . . ,Wn−1,Wn + Vn)ds
)
|Fn−1tn ∩ {T > tn}]
EP [exp
(
−
∫ t
tn
φs(W1, . . . ,Wn−1,Wn + Vn)ds
)
|Fn−1tn ∩ {T > tn}]
=
EP [h(Wn + Vn) exp
(
−
∫ t
tn
φs(W1, . . . ,Wn)ds
)
|Fn−1tn ∩ {T > tn}]
EP [exp
(
−
∫ t
tn
φs(W1, . . . ,Wn)ds
)
|Fn−1tn ∩ {T > tn}]
=EP [h(Wn + Vn)|F
n−1
t− ∩ {T > t}]
=EP [h(Wn + Vn)|T > t].
Suppose that (21) is satisfied for i = n, n− 1, . . . , j + 1. Now
EP˜ [h(Wj)|T > t]
=EP˜ [h(Wj)|F
j−1
t− ∩ {T > t}]
=
EP˜ [h(Wj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wn)ds
)
|F j−1tj ∩ {T > tj}]
EP˜ [exp
(
−
∫ t
tj
φs(W1, . . . ,Wn)ds
)
|F j−1tj ∩ {T > tj}]
=
EP˜ [h(Wj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wj , W˜j+1(s), . . . , W˜n(s))ds
)
|F j−1tj ∩ {T > tj}]
EP˜ [exp
(
−
∫ t
tj
φs(W1, . . . ,Wj , W˜j+1(s), . . . , W˜n(s))ds
)
|F j−1tj ∩ {T > tj}]
=
EP˜ [h(Wj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s) + Vj+1, . . . ,Wn(s) + Vn)ds
)
|F j−1tj ∩ {T > tj}]
EP˜ [exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s) + Vj+1, . . . ,Wn(s) + Vn)ds
)
|F j−1tj ∩ {T > tj}]]
=
EP [h(Wj + Vj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wj−1,Wj + Vj ,Wj+1(s) + Vj+1, . . . ,Wn(s) + Vn)ds
)
|F j−1tj ∩ {T > tj}]
EP [exp
(
−
∫ t
tj
φs(W1, . . . ,Wj−1,Wj + Vj ,Wj+1(s) + Vj+1, . . . ,Wn(s) + Vn)ds
)
|F j−1tj ∩ {T > tj}]
=
EP [h(Wj + Vj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s), . . . ,Wn(s)) + φs(0, . . . , 0, Vj , . . . , Vn)ds
)
|F j−1tj ∩ {T > tj}]
EP [exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s), . . . ,Wn(s)) + φs(0, . . . , 0, Vj , . . . , Vn)ds
)
|F j−1tj ∩ {T > tj}]
=
EP [h(Wj + Vj) exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s), . . . ,Wn(s)))ds
)
|F j−1tj ∩ {T > tj}]]
EP [exp
(
−
∫ t
tj
φs(W1, . . . ,Wj ,Wj+1(s), . . . ,Wn(s))ds
)
|F j−1tj ∩ {T > tj}]
=EP [h(Wj + Vj)|F
j−1
t ∩ {T > t}]
=EP [h(Wj + Vj)|T > t],
so (21) follows by induction.
Let α0t denote the hazard of T with respect to Nt and P , and let α˜
0
t denote the hazard we would
see if the frequencies had been governed by P˜ .
Now,
EP˜ [β
⊺
t JtX |T > t] = φt(EP˜ [W1|T > t], . . . , EP˜ [Wn|T > t])
=φt(EP [W1|T > t] + V1, . . . , EP [Wn|T > t] + Vn)
=φt(EP [W1|T > t], . . . , EP [Wn|T > t]) + φt(V1, . . . , Vn)
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By the Innovation Theorem, we have the following:
α˜0t = α
0
t + β
⊺
t Jt(I +∇i)(I +∇i−1) . . . (I +∇2)V. (22)
Finally, (13) follows by writing out the matrix products.
Proof of Proposition 1.
E
[
Xk
∣∣Fk−1t ] =E[ k−1∑
j=1
bk,jXj +Wk
∣∣Fk−1t ] = k−1∑
j=1
bk,jXj + E
[
Wk
∣∣Fk−1t ]
=
k−1∑
j=1
bk,jXj + E
[
Wk
∣∣T > t],
where the last equality follows since WkW1, . . . ,Wk−1|T > t by Lemma 1.
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